BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31341086)

  • 41. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.
    Martin HJ; Lee JM; Walls D; Hayward SD
    J Virol; 2007 Sep; 81(18):9748-58. PubMed ID: 17609264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.
    Coleman CB; Lang J; Sweet LA; Smith NA; Freed BM; Pan Z; Haverkos B; Pelanda R; Rochford R
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30089703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
    Schlee M; Krug T; Gires O; Zeidler R; Hammerschmidt W; Mailhammer R; Laux G; Sauer G; Lovric J; Bornkamm GW
    J Virol; 2004 Apr; 78(8):3941-52. PubMed ID: 15047810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells.
    Seto E; Moosmann A; Grömminger S; Walz N; Grundhoff A; Hammerschmidt W
    PLoS Pathog; 2010 Aug; 6(8):e1001063. PubMed ID: 20808852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases.
    Bernasconi M; Ueda S; Krukowski P; Bornhauser BC; Ladell K; Dorner M; Sigrist JA; Campidelli C; Aslandogmus R; Alessi D; Berger C; Pileri SA; Speck RF; Nadal D
    Int J Cancer; 2013 Nov; 133(10):2341-50. PubMed ID: 23640782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.
    Jud A; Kotur M; Berger C; Gysin C; Nadal D; Lünemann A
    Oncotarget; 2017 Jan; 8(4):6130-6141. PubMed ID: 28008151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
    Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
    Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restricted expression of Epstein-Barr virus latent genes in murine B cells derived from embryonic stem cells.
    Zychlinska M; Herrmann H; Zimber-Strobl U; Hammerschmidt W
    PLoS One; 2008 Apr; 3(4):e1996. PubMed ID: 18414672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of Epstein-Barr virus Latent Membrane Protein 2 expression on the kinetics of early B cell infection.
    Wasil LR; Tomaszewski MJ; Hoji A; Rowe DT
    PLoS One; 2013; 8(1):e54010. PubMed ID: 23308294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells.
    Wang L; Laing J; Yan B; Zhou H; Ke L; Wang C; Narita Y; Zhang Z; Olson MR; Afzali B; Zhao B; Kazemian M
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.
    Kalla M; Schmeinck A; Bergbauer M; Pich D; Hammerschmidt W
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):850-5. PubMed ID: 20080764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early events associated with infection of Epstein-Barr virus infection of primary B-cells.
    Halder S; Murakami M; Verma SC; Kumar P; Yi F; Robertson ES
    PLoS One; 2009 Sep; 4(9):e7214. PubMed ID: 19784370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival.
    Wang LW; Wang Z; Ersing I; Nobre L; Guo R; Jiang S; Trudeau S; Zhao B; Weekes MP; Gewurz BE
    PLoS Pathog; 2019 Sep; 15(9):e1008030. PubMed ID: 31518366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells.
    Al Tabaa Y; Tuaillon E; Bollore K; Foulongne V; Petitjean G; Seigneurin JM; Duperray C; Desgranges C; Vendrell JP
    Blood; 2009 Jan; 113(3):604-11. PubMed ID: 18845794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1.
    Skinner CM; Ivanov NS; Barr SA; Chen Y; Skalsky RL
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epstein-Barr virus (EBV) infection visualized by EGFP expression demonstrates dependence on known mediators of EBV entry.
    Speck P; Longnecker R
    Arch Virol; 1999; 144(6):1123-37. PubMed ID: 10446648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.
    Niller HH; Wolf H; Minarovits J
    Semin Cancer Biol; 2009 Jun; 19(3):158-64. PubMed ID: 19429479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.
    Martorelli D; Muraro E; Mastorci K; Dal Col J; Faè DA; Furlan C; Giagulli C; Caccuri F; Rusnati M; Fiorentini S; Carbone A; Caruso A; Dolcetti R
    Int J Cancer; 2015 Sep; 137(6):1374-85. PubMed ID: 25704763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection.
    Saha A; Jha HC; Upadhyay SK; Robertson ES
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5199-207. PubMed ID: 26324942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.